Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES Ekstrand M. I., Falkenberg M., Rantanen A., Park C. B., Gaspari M., Hultenby K., Rustin P., 194 Gustafsson C. M. and Larsson N. G. (2004) Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 13, 935–944. Elliott H. L., Dryburgh F., Fell G. S., Sabet S. and Macdougall A. I. (1978) Aluminum toxicity during regular haemodialysis. Br. Med. J. 1, 1101–1103. El-Rahman S. S. (2003) Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol. Res. 47, 189–194. Emre M. (2003) Dementia associated with Parkinson’s disease. Lancet Neurol. 2, 229–237. Engel L. S., Checkoway H., Keifer M. C., Seixas N. S., Longstreth W. T. Jr., Scott K. C., Hudnell K., Anger W. K. and Camicioli R. (2001) Parkinsonism and occupational exposure to pesticides. Occup. Environ. Med. 58, 582–589. Eriksen J. L., Wszolek Z. and Petrucelli L. (2005) Molecular pathogenesis of Parkinson disease. Arch. Neurol. 62, 353–357. Esparza J. L., Gómez M., Romeu M., Mulero M., Sánchez D. J., Mallol J. and Domingo J. L. (2003) Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin. J. Pineal Res. 35, 32–39. Esparza J. L., Gómez M., Nogués M. R., Paternain J. L., Mallol J. and Domingo J. L. (2005) Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J. Pineal Res. 39, 129–136. Exley C. (1998) Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer’s disease? Mol. Med. Today 4, 107–109. Exley C. (1999) A molecular mechanism of aluminium induced Alzheimer's disease? J. Inorg. Biochem. 76, 133–140. Exley C. (2004a) The pro-oxidant activity of aluminum. Free Radic. Biol. Med. 36, 380–387.
REFERENCES Exley C. (2004b) Aluminum in antiperspirants: more than just skin deep. Am. J. Med. 117, 969– 970. Exley C. and Esiri M. M. (2006) Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK. J. Neurol. Neurosurg. Psychiatry 77, 877–879. Exley C., Burgess E., Day J. P., Jeffery E. H., Melethil S. and Yokel R. A. (1996) Aluminum toxicokinetics. J. Toxicol. Environ. Health 48, 569–584. Fahn S. (2003) Description of Parkinson’s disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 991, 1–14. Fahn S. and Przedborski S. (2000) Parkinsonism, in Merritt's Neurology (Rowland L. P., ed), pp. 679–693. Lippincott Williams & Wilkins, New York. Fahn S. and Sulzer D. (2004) Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx. 1, 139–154. Faull R. L. and Laverty R. (1969) Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. Exp. Neurol. 23, 332–340. Fearnley J. M. and Lees A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283–2301. Flarend R., Bin T., Elmore D. and Hem S. L. (2001) A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem. Toxicol. 39, 163–168. Flaten T. P. (2001) Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res. Bull. 55, 187–196. Flaten T. P., Glattre E., Viste A. and Søoreide O. (1991) Mortality from dementia among gastroduodenal ulcer patients. J. Epidemiol. Community Health, 45, 203–206. 195
- Page 168 and 169: CHAPTER 3 Fig. 5 Levels of TBARS (A
- Page 170 and 171: CHAPTER 3 Fig. 6 In vitro effects o
- Page 173: SUMMARY
- Page 176 and 177: SUMMARY values were attained at 48
- Page 178 and 179: SUMMARY neurodegeneration in the DA
- Page 181 and 182: CONCLUSIONS The results obtained in
- Page 183: 13) Aluminium does affect neither M
- Page 187 and 188: RESUMEN RESUMEN Desde el punto de v
- Page 189 and 190: RESUMEN zonas cerebrales excepto en
- Page 191: CONCLUSIONES
- Page 194 and 195: CONCLUSIONES Capítulo 2 4) La admi
- Page 196 and 197: CONCLUSIONES 172 En base a las conc
- Page 199 and 200: Publications as a direct result fro
- Page 201: REFERENCES
- Page 204 and 205: REFERENCES Agil A., Duran R., Barre
- Page 206 and 207: REFERENCES Baquet Z. C., Bickford P
- Page 208 and 209: REFERENCES 184 1,2,3,6-tetrahydropy
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 212 and 213: REFERENCES Chung K. K., Dawson V. L
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 222 and 223: REFERENCES Ghribi O., Dewitt D. A.,
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 240 and 241: REFERENCES Maraganore D. M., Lesnic
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 244 and 245: REFERENCES Miu A. C. and Benga O. (
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 254 and 255: REFERENCES Rifat S. L., Eastwood M.
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
- Page 258 and 259: REFERENCES Savory J., Herman M. M.
- Page 260 and 261: REFERENCES Shimizu H., Mori T., Koy
- Page 262 and 263: REFERENCES 238 the generation of hy
- Page 264 and 265: REFERENCES Taylor G. A., Moore P. B
- Page 266 and 267: REFERENCES Um J. W., Stichel-Gunkel
REFERENCES<br />
Ekstrand M. I., Falkenberg M., Rantanen A., Park C. B., Gaspari M., Hultenby K., Rust<strong>in</strong> P.,<br />
194<br />
Gustafsson C. M. and Larsson N. G. (2004) Mitochondrial transcription factor A regulates<br />
mtDNA copy number <strong>in</strong> mammals. Hum. Mol. Genet. 13, 935–944.<br />
Elliott H. L., Dryburgh F., Fell G. S., Sabet S. and Macdougall A. I. (1978) Alum<strong>in</strong>um toxicity<br />
dur<strong>in</strong>g regular haemodialysis. Br. Med. J. 1, 1101–1103.<br />
El-Rahman S. S. (2003) Neuropathology <strong>of</strong> alum<strong>in</strong>um toxicity <strong>in</strong> rats (glutamate and GABA<br />
impairment). Pharmacol. Res. 47, 189–194.<br />
Emre M. (2003) Dementia associated with Park<strong>in</strong>son’s disease. Lancet Neurol. 2, 229–237.<br />
Engel L. S., Checkoway H., Keifer M. C., Seixas N. S., Longstreth W. T. Jr., Scott K. C., Hudnell K.,<br />
Anger W. K. and Camicioli R. (2001) Park<strong>in</strong>sonism and occupational exposure to pesticides.<br />
Occup. Environ. Med. 58, 582–589.<br />
Eriksen J. L., Wszolek Z. and Petrucelli L. (2005) Molecular pathogenesis <strong>of</strong> Park<strong>in</strong>son disease.<br />
Arch. Neurol. 62, 353–357.<br />
Esparza J. L., Gómez M., Romeu M., Mulero M., Sánchez D. J., Mallol J. and Dom<strong>in</strong>go J. L.<br />
(2003) Alum<strong>in</strong>um-<strong>in</strong>duced pro-oxidant effects <strong>in</strong> rats: protective role <strong>of</strong> exogenous<br />
melaton<strong>in</strong>. J. P<strong>in</strong>eal Res. 35, 32–39.<br />
Esparza J. L., Gómez M., Nogués M. R., Paterna<strong>in</strong> J. L., Mallol J. and Dom<strong>in</strong>go J. L. (2005)<br />
Melaton<strong>in</strong> reduces <strong>oxidative</strong> <strong>stress</strong> and <strong>in</strong>creases gene expression <strong>in</strong> the cerebral cortex<br />
and cerebellum <strong>of</strong> alum<strong>in</strong>um-exposed rats. J. P<strong>in</strong>eal Res. 39, 129–136.<br />
Exley C. (1998) Does antiperspirant use <strong>in</strong>crease the risk <strong>of</strong> <strong>alum<strong>in</strong>ium</strong>-related disease,<br />
<strong>in</strong>clud<strong>in</strong>g Alzheimer’s disease? Mol. Med. Today 4, 107–109.<br />
Exley C. (1999) A molecular mechanism <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> <strong>in</strong>duced Alzheimer's disease? J. Inorg.<br />
Biochem. 76, 133–140.<br />
Exley C. (2004a) The pro-oxidant activity <strong>of</strong> alum<strong>in</strong>um. Free Radic. Biol. Med. 36, 380–387.
Change language